The Allstate Corporation ALL
260.89 USD +7.09 (+2.80%)
Nov 10, 2026, 1:43 PM EST
254.95 Day range 260.89
192.28 52-week range 275.11
- YTD
- +25.34%
- 1 year
- +27.95%
News
benzinga.com Morgan Stanley Maintains Equal-Weight on Allstate, Raises Price Target to $260 Morgan Stanley analyst Bob Huang maintains Allstate (NYSE:ALL) with a Equal-Weight and raises the price target from $240 to $260.
youtube.com Watch CNBC's full interview with Allstate CEO Tom Wilson Allstate CEO Tom Wilson joins CNBC's Morgan Brennan live at the B20 USA Summit to discuss trust, insurance affordability, autonomous vehicles, AI and the economy.
benzinga.com Keefe, Bruyette & Woods Maintains Underperform on Allstate, Raises Price Target to $241 Keefe, Bruyette & Woods analyst Meyer Shields maintains Allstate (NYSE:ALL) with a Underperform and raises the price target from $232 to $241.
prnewswire.com Allstate Thanksgiving Driver Report: What drivers should know before hitting the road High-speed driving jumps nearly 200% Thanksgiving morning, according to Allstate Drivewise data, with new insights showing when and where drivers should take extra care. Key takeaways: Allow extra…
benzinga.com Piper Sandler Maintains Overweight on Allstate, Lowers Price Target to $294 Piper Sandler analyst Paul Newsome maintains Allstate (NYSE:ALL) with a Overweight and lowers the price target from $300 to $294.
seekingalpha.com Do. Not. Panic. Allstate (ALL) stands out as a Quant Strong Buy, up 38% over the last year and outperforming the S&P 500 and financial sector. Market volatility is not driven by a debt bubble; strong earnings and…- benzinga.com Citigroup Maintains Sell on Allstate, Raises Price Target to $225 Citigroup analyst Matthew Heimermann maintains Allstate (NYSE:ALL) with a Sell and raises the price target from $215 to $225.
benzinga.com Wells Fargo Maintains Equal-Weight on Allstate, Raises Price Target to $252 Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Equal-Weight and raises the price target from $236 to $252.- benzinga.com Barclays Maintains Underweight on Allstate, Raises Price Target to $228 Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and raises the price target from $221 to $228.
benzinga.com Allstate Q3 2026 Earnings Call Transcript Allstate (NYSE:ALL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com Evercore ISI Group Maintains In-Line on Allstate, Raises Price Target to $269 Evercore ISI Group analyst Oliver Wintermantel maintains Allstate (NYSE:ALL) with a In-Line and raises the price target from $262 to $269.
zacks.com Compared to Estimates, Allstate (ALL) Q3 Earnings: A Look at Key Metrics Although the revenue and EPS for Allstate (ALL) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
zacks.com Allstate (ALL) Tops Q3 Earnings and Revenue Estimates Allstate (ALL) came out with quarterly earnings of $9.76 per share, beating the Zacks Consensus Estimate of $7.03 per share. This compares to earnings of $11.17 per share a year ago.
prnewswire.com Allstate Reports Excellent Q3 2026 Results NORTHBROOK, Ill., Nov. 4, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) today reported financial results for the third quarter of 2026.
benzinga.com Here's How Much $1000 Invested In Allstate 10 Years Ago Would Be Worth Today Allstate (NYSE:ALL) has outperformed the market over the past 10 years by 1.09% on an annualized basis producing an average annual return of 14.51%. Currently, Allstate has a market capitalization of…
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
zacks.com ALL, MET, AFL or PRI: Which Insurer Has the Edge for a Q3 Beat? Third-quarter 2026 earnings are rolling in, and insurers are moving into focus. Major players like Marsh, Aon and The Hartford have already reported solid year-over-year growth, offering an early…
benzinga.com Here's How Much $100 Invested In Allstate 15 Years Ago Would Be Worth Today Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 3.07% on an annualized basis producing an average annual return of 16.04%. Currently, Allstate has a market capitalization of…
benzinga.com Travelers Companies Is Likely ‘Overearning,’ Says Bearish Analyst Bank of America says Travelers is “overearning,” citing declining policies, slowing underwriting profits and a rich valuation.
benzinga.com Allstate Reports Q3 Estimated Total Catastrophe Losses Of $1.65B Or $1.3B After-Tax The Allstate Corporation (NYSE:ALL) today announced estimated catastrophe losses for the month of September of $220 million or $173 million, after-tax.
benzinga.com Wells Fargo Upgrades Allstate to Equal-Weight, Lowers Price Target to $236 Wells Fargo analyst Elyse Greenspan upgrades Allstate (NYSE:ALL) from Underweight to Equal-Weight and lowers the price target from $250 to $236.- benzinga.com Keefe, Bruyette & Woods Maintains Underperform on Allstate, Lowers Price Target to $232 Keefe, Bruyette & Woods analyst Meyer Shields maintains Allstate (NYSE:ALL) with a Underperform and lowers the price target from $250 to $232.
benzinga.com Transcript: Allstate Q2 2026 Earnings Conference Call Allstate (NYSE:ALL) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga…
benzinga.com Mizuho Maintains Outperform on Allstate, Lowers Price Target to $295 Mizuho analyst Yaron Kinar maintains Allstate (NYSE:ALL) with a Outperform and lowers the price target from $300 to $295.- benzinga.com Barclays Maintains Underweight on Allstate, Lowers Price Target to $221 Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $226 to $221.
benzinga.com Elizabeth Warren, Josh Hawley Launch Probe Into Insurance Giants Over Claims That End With $0 Payouts — State Farm, Allstate Face Tough Questions: Report (UPDATED) Warren and Hawley are pressing insurers like State Farm and Allstate to explain why more home and auto claims go unpaid.- benzinga.com Morgan Stanley Maintains Equal-Weight on Allstate, Lowers Price Target to $240 Morgan Stanley analyst Bob Huang maintains Allstate (NYSE:ALL) with a Equal-Weight and lowers the price target from $265 to $240.
- benzinga.com Goldman Sachs Maintains Neutral on Allstate, Lowers Price Target to $250 Goldman Sachs analyst Robert Cox maintains Allstate (NYSE:ALL) with a Neutral and lowers the price target from $280 to $250.
benzinga.com $1000 Invested In Allstate 15 Years Ago Would Be Worth This Much Today Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 2.74% on an annualized basis producing an average annual return of 16.61%. Currently, Allstate has a market capitalization of…- benzinga.com Mizuho Maintains Outperform on Allstate, Raises Price Target to $300 Mizuho analyst Yaron Kinar maintains Allstate (NYSE:ALL) with a Outperform and raises the price target from $297 to $300.
benzinga.com Allstate Reports August Catastrophe Losses Of $748M, Post-Tax Of $591M Catastrophe losses for August include 21 events with approximately 50% of the losses related to one wind and hail event. Total catastrophe losses for July and August were $1.43 billion or $1.13…- benzinga.com Mizuho Maintains Outperform on Allstate, Lowers Price Target to $297 Mizuho analyst Yaron Kinar maintains Allstate (NYSE:ALL) with a Outperform and lowers the price target from $300 to $297.
- benzinga.com Here's How Much $1000 Invested In Allstate 15 Years Ago Would Be Worth Today Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 3.51% on an annualized basis producing an average annual return of 16.86%. Currently, Allstate has a market capitalization of…
benzinga.com Here’s How Much You Would Have Made Owning Allstate Stock In The Last 15 Years Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 3.61% on an annualized basis producing an average annual return of 16.97%. Currently, Allstate has a market capitalization of…
benzinga.com This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday Wall Street analysts changed outlook on top names. Check all rating changes, including upgrades/downgrades, on Benzinga analyst ratings page.- benzinga.com Keefe, Bruyette & Woods Downgrades Allstate to Underperform, Lowers Price Target to $250 Keefe, Bruyette & Woods analyst Meyer Shields downgrades Allstate (NYSE:ALL) from Market Perform to Underperform and lowers the price target from $255 to $250.
- benzinga.com $100 Invested In Allstate 15 Years Ago Would Be Worth This Much Today Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 3.38% on an annualized basis producing an average annual return of 17.11%. Currently, Allstate has a market capitalization of…
- benzinga.com Citigroup Downgrades Allstate to Sell, Raises Price Target to $240 Citigroup analyst Matthew Heimermann downgrades Allstate (NYSE:ALL) from Neutral to Sell and raises the price target from $226 to $240.
benzinga.com JP Morgan Maintains Overweight on Allstate, Raises Price Target to $292 JP Morgan analyst Pablo Singzon maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $282 to $292.- benzinga.com UBS Maintains Neutral on Allstate, Raises Price Target to $275 UBS analyst Brian Meredith maintains Allstate (NYSE:ALL) with a Neutral and raises the price target from $261 to $275.
- benzinga.com Piper Sandler Maintains Overweight on Allstate, Raises Price Target to $300 Piper Sandler analyst Paul Newsome maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $268 to $300.
benzinga.com Wells Fargo Downgrades Allstate to Underweight, Raises Price Target to $250 Wells Fargo analyst Elyse Greenspan downgrades Allstate (NYSE:ALL) from Equal-Weight to Underweight and raises the price target from $243 to $250.- benzinga.com Evercore ISI Group Maintains In-Line on Allstate, Raises Price Target to $262 Evercore ISI Group analyst Oliver Wintermantel maintains Allstate (NYSE:ALL) with a In-Line and raises the price target from $240 to $262.
- benzinga.com Barclays Maintains Underweight on Allstate, Raises Price Target to $226 Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and raises the price target from $213 to $226.
- benzinga.com Allstate Q2 Adj. EPS $8.99 Beats $6.12 Estimate, Sales $18.596B Beat $15.658B Estimate Allstate (NYSE:ALL) reported quarterly earnings of $8.99 per share which beat the analyst consensus estimate of $6.12 by 46.9 percent. This is a 51.35 percent increase over earnings of $5.94 per…
benzinga.com This Arthur J. Gallagher Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Top Wall Street analysts upgraded AJG, CNX, NXT, CAVA, and DLR stocks and raised price targets. See what other analysts say about these stocks.
benzinga.com This Check Point Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Analysts changed outlook on top Wall Street names. Check ratings page for upgrades, downgrades, and initiations. See what they think of AIG, CHKP, AON, ALL, and THG.- benzinga.com UBS Downgrades Allstate to Neutral, Raises Price Target to $261 UBS analyst Brian Meredith downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $255 to $261.
- benzinga.com Allstate Appoints Christian Lown CFO, Effective Aug. 3, Succeeding Jess Merten The Allstate Corporation (NYSE: ALL) today announced Christian (Chris) Lown as Executive Vice President and Chief Financial Officer, effective Aug. 3. Lown will report to Tom Wilson, Chair, President…
- benzinga.com JP Morgan Maintains Overweight on Allstate, Raises Price Target to $282 JP Morgan analyst Jimmy Bhullar maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $263 to $282.